1. Home
  2. BOLD vs SELX Comparison

BOLD vs SELX Comparison

Compare BOLD & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • SELX
  • Stock Information
  • Founded
  • BOLD 2018
  • SELX 2021
  • Country
  • BOLD United States
  • SELX Taiwan
  • Employees
  • BOLD N/A
  • SELX N/A
  • Industry
  • BOLD
  • SELX
  • Sector
  • BOLD
  • SELX
  • Exchange
  • BOLD Nasdaq
  • SELX Nasdaq
  • Market Cap
  • BOLD 60.4M
  • SELX 55.4M
  • IPO Year
  • BOLD 2024
  • SELX N/A
  • Fundamental
  • Price
  • BOLD $2.35
  • SELX $1.32
  • Analyst Decision
  • BOLD Strong Buy
  • SELX
  • Analyst Count
  • BOLD 3
  • SELX 0
  • Target Price
  • BOLD $23.00
  • SELX N/A
  • AVG Volume (30 Days)
  • BOLD 84.8K
  • SELX 5.7K
  • Earning Date
  • BOLD 11-07-2024
  • SELX 01-01-0001
  • Dividend Yield
  • BOLD N/A
  • SELX N/A
  • EPS Growth
  • BOLD N/A
  • SELX N/A
  • EPS
  • BOLD N/A
  • SELX N/A
  • Revenue
  • BOLD N/A
  • SELX $1,071,872.00
  • Revenue This Year
  • BOLD N/A
  • SELX N/A
  • Revenue Next Year
  • BOLD N/A
  • SELX N/A
  • P/E Ratio
  • BOLD N/A
  • SELX N/A
  • Revenue Growth
  • BOLD N/A
  • SELX N/A
  • 52 Week Low
  • BOLD $2.33
  • SELX $0.77
  • 52 Week High
  • BOLD $15.24
  • SELX $12.15
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • SELX 38.11
  • Support Level
  • BOLD N/A
  • SELX $1.19
  • Resistance Level
  • BOLD N/A
  • SELX $1.62
  • Average True Range (ATR)
  • BOLD 0.00
  • SELX 0.10
  • MACD
  • BOLD 0.00
  • SELX -0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • SELX 25.20

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: